Molecular Characterization of HER2-negative Breast Cancers Reveals a Distinct Patient Subgroup with 17q12 Deletion and Heterozygous Loss of ERBB2

X. Qiu,P. Tarantino, R. Li,A. Grinshpun, H. Gupta,M. E. Hughes, G. Kirkner, L. Scholl, B. E. Johnson, M. Meyerson,A. D. Cherniack, Y. Jiang, N. Zhou,N. U. Lin, H. W. Long,S. M. Tolaney,R. Jeselsohn

ESMO OPEN（2025）

Cited 0|Views1

Key words

breast cancer,HER2 low,ERBB2 mRNA,ERBB2 heterozygous loss

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined